VERFAHREN

European patent · EP3171891 · In force

Register entry

Publication number
EP3171891
Application number
EP15756845
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 10, 2015
Published
May 31, 2017
Granted
Sep 10, 2025
Protection ends at the latest
Jul 9, 2035
Next annual fee due
Jul 31, 2027
IPC classes
A61K 39/395 (2006.01)
C12N 9/24 (2006.01)
Priority
GB 201413240 25.07.2014
PCT application
PCT/EP2015/065895 10.07.2015
PCT publication
WO2016/012285 28.01.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Jul 22, 2026

    Change

    Published in Swissreg on 22.07.2026

  3. Nov 18, 2025

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 18.11.2025

  4. Sep 10, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.09.2025

Parties

Holder

Hansa Biopharma AB

Box 785, 220 07 Lund, SE

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

KJELLMAN, Christian

SE 220 07 Lund, SE

JARNUM, Sofia

SE 220 07 Lund, SE

WINSTEDT, Lena

SE 220 07 Lund, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.